Association of BMI with mortality and health-related quality of life among 4.4 million adults: evidence from a nationwide, population-based, prospective cohort study
Wu Y, Lin C, Wang C, et al.
Diabetes Obes Metab. Pub. online 14 Mar 2025.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Real-world use of tirzepatide among individuals without evidence of type 2 diabetes: results from the Veradigm® database
Hunter Gibble T, Chinthammit C, Ward JM, et al.
Diabetes Obes Metab. Pub. online 14 Mar 2025.
Leggi
Continuous ranibizumab via port delivery system vs monthly ranibizumab for treatment of diabetic macular edema: the pagoda randomized clinical trial
Khanani AM, Campochiaro PA, Graff JM, et al.
JAMA Ophthalmol. 2025:e250006.
Leggi
Port delivery system with ranibizumab vs monitoring in nonproliferative diabetic retinopathy without macular edema: the pavilion randomized clinical trial
Pieramici DJ, Awh CC, Chang M, et al.
JAMA Ophthalmol. 2025:e250001.
Leggi
Differential effects of type 2 diabetes and gestational diabetes on maternal and cord blood adipokines and newborn weight
Gruber BL, Rawal Y, Irabor P, et al.
BMC Pregnancy Childbirth. 2025;25(1):238.
Leggi
Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: a target trial emulation study
Ju C, Xiong X, Lui DTW, et al.
Diabetes Res Clin Pract. 2025:112082.
Leggi
Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes
Tsoi AT, Sng J, Tummanapalli SS, et al.
Diabetologia. Pub. online 7 Mar 2025.
Leggi
The impact of sodium-glucose cotransporter-2 inhibitors on atrial fibrillation burden in diabetic patients
Kidess GG, Hamza M, Goru R, et al.
Am J Cardiol. Pub. online 7 Mar 2025.
Leggi
Multivitamins after myocardial infarction in patients with diabetes: a randomized clinical trial
Ujueta F, Lamas GA, Anstrom KJ, et al.
JAMA Intern Med. 2025:e248408.
Leggi
Hematologic cancers among patients with type 2 diabetes prescribed GLP-1 receptor agonists
Ashruf OS, Hundal J, Mushtaq A, et al.
JAMA Netw Open. 2025;8(3):e250802.
Leggi